I get the feeling people were expecting a better quarterly. We might be in for a bit of a price drop for now. Not many buyers at all. Great time to top up.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025